S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Closing prices for crude oil, gold and other commodities

Fulcrum Therapeutics (FULC) Earnings Date, Estimates & Call Transcripts

$7.36
-0.14 (-1.87%)
(As of 04/15/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 20Estimated
Actual EPS
(Feb. 27)
-$0.40 Beat By $0.04
Consensus EPS
(Feb. 27)
-$0.44
Skip Charts & View Estimated and Actual Earnings Data

FULC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FULC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fulcrum Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.46)($0.40)($0.43)
Q2 20242($0.45)($0.40)($0.43)
Q3 20242($0.44)($0.41)($0.43)
Q4 20242($0.43)($0.41)($0.42)
FY 20248($1.78)($1.62)($1.70)

FULC Earnings Date and Information

Fulcrum Therapeutics last posted its earnings results on February 27th, 2024. The reported ($0.40) EPS for the quarter, topping analysts' consensus estimates of ($0.44) by $0.04. The firm earned $0.87 million during the quarter, compared to the consensus estimate of $0.65 million. Fulcrum Therapeutics has generated ($1.58) earnings per share over the last year (($1.58) diluted earnings per share). Earnings for Fulcrum Therapeutics are expected to grow in the coming year, from ($1.76) to ($1.74) per share. Fulcrum Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Fulcrum Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
2/27/2024Q4 2023($0.44)($0.40)+$0.04($0.40)$0.65 million$0.87 million
11/7/2023Q3 2023($0.44)($0.39)+$0.05($0.39)$1.81 million$0.76 million
8/3/2023Q2 2023($0.44)($0.38)+$0.06($0.38)$1.60 million$0.88 million
5/15/2023Q1 2023($0.47)($0.41)+$0.06($0.41)$1.73 million$0.30 million
3/9/2023Q4 2022($0.49)($0.50)($0.01)($0.50)$1.92 million$0.69 million
11/8/2022Q3 2022($0.62)($0.50)+$0.12($0.49)$2.19 million$1.18 million
8/11/2022Q2 2022($0.66)($0.83)($0.17)($0.83)$2.65 million$1.88 million
5/9/2022Q1 2022($0.63)($0.64)($0.01)($0.64)$3.46 million$2.59 million
3/3/2022Q4 2021($0.65)($0.58)+$0.07($0.58)$4.00 million$5.06 million    
11/4/2021Q3 2021($0.64)($0.57)+$0.07($0.57)$2.94 million$4.94 million    
8/10/2021Q2 2021($0.65)($0.60)+$0.05($0.60)$2.69 million$4.38 million    
5/6/2021Q1 2021($0.66)($0.54)+$0.12($0.54)$2.18 million$4.79 million  

Fulcrum Therapeutics Earnings - Frequently Asked Questions

When is Fulcrum Therapeutics's earnings date?

Fulcrum Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on FULC's earnings history.

Did Fulcrum Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Fulcrum Therapeutics (NASDAQ:FULC) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.44) by $0.04. Learn more on analysts' earnings estimate vs. FULC's actual earnings.

How much revenue does Fulcrum Therapeutics generate each year?

Fulcrum Therapeutics (NASDAQ:FULC) has a recorded annual revenue of $2.81 million.

How much profit does Fulcrum Therapeutics generate each year?

Fulcrum Therapeutics (NASDAQ:FULC) has a recorded net income of -$97.33 million. FULC has generated -$1.58 earnings per share over the last four quarters.

What is Fulcrum Therapeutics's EPS forecast for next year?

Fulcrum Therapeutics's earnings are expected to grow from ($1.76) per share to ($1.74) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:FULC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners